671 Search Results for: new to drug testing
Quest Diagnostics tests for synthetic cannabinoids
Quest Diagnostics now offers a synthetic cannabinoids panel testing for AM-2201, JWH-018, JWH-019, JWH-073, JWH-250, UR-144 and XLR11 compounds.
National treatment admissions for opiates increase
The percentage of admissions substance abuse treatment facilities for individuals who primarily abused opiates other than heroin increased.
Marijuana use continues to increase
According to the NSDUH survey, there has been a steady increase in marijuana users over the last four years.
Trust the name. Trust the numbers.
Trust Quest Diagnostics as a reliable, accurate drug testing provider because we offer broad access, extensive testing, insightful data and resources.
SAPAA’s Annual conference
As a platinum sponsor of the SAPAA conference, we couldn't be more excited about this gathering of thought leaders and experts from the industry.
Quest Diagnostics now tests for synthetic stimulants (bath salts)
Quest Diagnostics offers a comprehensive suite of drug testing products and services which now includes testing for synthetic stimulants (bath salts).
On-site mobile collections
Whether we collect the specimen at a collection site or at your place of business, the same standardized processes are used for consistent quality.
Fixed-site collection network
Quest Diagnostics provides unparalleled access to a combined nationwide network of more than 8,000 drug testing collection sites.
DOT’s top 10 steps to collection site security and integrity
By following these 10 steps, our collection sites continually ensure that they maintain the integrity of the collection process.
Quest Diagnostics honored with American Cancer Society award
Quest Diagnostics receives the Excellence in Employee Engagement award from the American Cancer Society for its efforts and participation in 2012.
